Home

Kristi Ann Matus

CIK 1543504 · EVP and CFAO · last filed 2026-07-07

Kristi Ann Matus is an EVP and CFAO who has filed 52 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing, for OSG, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions. 13 SEC filings were submitted jointly with ATHENAHEALTH INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.81M

Companies

7

Total Filings

52

Lifetime Open-Market Net

-$1.61M

Filer Profile

Reported Address
C/O OCTAVE SPECIALTY GROUP, INC.
40 WALL STREET, 55TH FLOOR
NEW YORK, NY 10005
Related Filers
ATHENAHEALTH INC — 13 joint filings, latest 2016-05-03
Equitable Holdings, Inc. — 8 joint filings, latest 2023-03-24
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OSG Director — $4.84 — $0 3 2026-07-07
UNMA Director 2,191 $21.45 $47.0K $0 1 2026-05-28
CRNC Director 54,737 $8.51 $465.8K -$399.6K 9 2026-02-13
OCTAVE SPECIALTY GROUP INC (AMBC) Delisted Director 48,179 $8.85 $426.4K $100.7K 13 2025-10-02
EQH Director 10,615 $53.34 $566.2K -$774.0K 7 2023-03-24
AB Director 20,254 $36.09 $731.0K $0 3 2022-05-23
ATHENAHEALTH INC (ATHN) Delisted EVP and CFAO 34,316 $9.59 $329.1K -$533.8K 12 2016-05-03

Recent Filings

52 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 OSG Grant (A) — $0 EDGAR
2026-05-28 UNMA Grant (A) +2,191 $0 EDGAR
2026-04-02 OSG Grant (A) — $0 EDGAR
2026-02-13 CRNC Grant (A) +12,968 $130 EDGAR
2026-01-05 OSG Grant (A) — $0 EDGAR
2025-10-02 OCTAVE SPECIALTY GROUP INC (AMBC) Delisted Grant (A) — $0 EDGAR
2025-09-30 OCTAVE SPECIALTY GROUP INC (AMBC) Delisted Conv (C) +39,179 $0 EDGAR
2025-07-01 OCTAVE SPECIALTY GROUP INC (AMBC) Delisted Grant (A) — $0 EDGAR
2025-04-02 OCTAVE SPECIALTY GROUP INC (AMBC) Delisted Grant (A) — $0 EDGAR
2025-02-18 CRNC Grant (A) +9,955 $100 EDGAR
Showing 1–10 of 52
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.